Myocardial infarction in children is an infrequent phenomenon. Here, we are reporting a case of paediatric systemic lupus erythematosus with autoimmune haemolytic anaemia and anti-phospholipid ...
Cardiovascular disease remains the leading cause of mortality worldwide, necessitating deeper insights into its molecular ...
This important work identifies phlda2 as a specific marker for primordial cardiomyocytes in the adult zebrafish heart and demonstrates their essential role in myocardial morphogenesis and coronary ...
Myocardial ischemia is a drop in blood flow to the heart. Myocardial infarction, or heart attack, occurs when death or damage occurs in the muscle tissue of the heart due to low blood supply. The ...
"Cardiovascular disease is the main cause of death in women, killing seven times more than breast cancer, notes Manzo-Silberman. The hospital death rate is significantly higher in women and, despite ...
The presence of myocardial viability at baseline was not a predictor of the long-term mortality reduction attained with CABG in patients with ischemic cardiomyopathy in the STICH trial, even when ...
A bivalent messenger RNA vaccine targeting both the ancestral and omicron BA.4–BA.5 sublineages of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Pfizer–BioNTech) was introduced in ...
Myocardial infarction (MI) – more regularly known as a heart attack – is an acute phenomenon initiated by the interruption of blood supply to regions of the heart, causing myocardial necrosis.
Dr. Patrick Malecha (Medicine): A 69-year-old man with a history of myocardial infarction, ischemic cardiomyopathy, and an implantable cardioverter–defibrillator (ICD) was evaluated because of dyspnea ...
Empagliflozin stabilizes kidney function and reduces heart failure risk post-myocardial infarction, with eGFR remaining stable over 24 months. The EMPACT-MI trial confirmed empagliflozin's safety when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results